Submission Details
| 510(k) Number | K173006 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 27, 2017 |
| Decision Date | November 28, 2017 |
| Days to Decision | 62 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K173006 is an FDA 510(k) clearance for the Cefaly Dual, a Stimulator, Nerve, Electrical, Transcutaneous, For Migraine (Class II — Special Controls, product code PCC), submitted by Cefaly Technology (Seraing, BE). The FDA issued a Cleared decision on November 28, 2017, 62 days after receiving the submission on September 27, 2017. This device falls under the Neurology review panel. Regulated under 21 CFR 882.5891.
| 510(k) Number | K173006 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 27, 2017 |
| Decision Date | November 28, 2017 |
| Days to Decision | 62 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | PCC — Stimulator, Nerve, Electrical, Transcutaneous, For Migraine |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.5891 |
| Definition | Used To Apply An Electrical Current To A Patient's Cranium Through Electrodes Placed On The Skin. |